SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-262644
Filing Date
2022-10-14
Accepted
2022-10-14 08:48:02
Documents
14
Period of Report
2022-10-13
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d369766d8k.htm   iXBRL 8-K 40032
2 EX-3.1 d369766dex31.htm EX-3.1 6697
3 EX-3.2 d369766dex32.htm EX-3.2 65828
  Complete submission text file 0001193125-22-262644.txt   263165

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fmtx-20221013.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmtx-20221013_lab.xml EX-101.LAB 18741
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmtx-20221013_pre.xml EX-101.PRE 11729
8 EXTRACTED XBRL INSTANCE DOCUMENT d369766d8k_htm.xml XML 3574
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39333 | Film No.: 221310330
SIC: 2836 Biological Products, (No Diagnostic Substances)